- Home
- OLP vs EYPT Comparison
OLP vs EYPT Comparison
Compare OLP & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLP
- EYPT
- Stock Information
- Founded
- OLP 1982
- EYPT 1987
- Country
- OLP United States
- EYPT United States
- Employees
- OLP N/A
- EYPT N/A
- Industry
- OLP Real Estate Investment Trusts
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- OLP Real Estate
- EYPT Industrials
- Exchange
- OLP Nasdaq
- EYPT Nasdaq
- Market Cap
- OLP 569.9M
- EYPT 579.4M
- IPO Year
- OLP N/A
- EYPT 2005
- Fundamental
- Price
- OLP $23.80
- EYPT $9.48
- Analyst Decision
- OLP Strong Buy
- EYPT Strong Buy
- Analyst Count
- OLP 1
- EYPT 8
- Target Price
- OLP $28.00
- EYPT $24.75
- AVG Volume (30 Days)
- OLP 70.5K
- EYPT 821.1K
- Earning Date
- OLP 08-05-2025
- EYPT 08-06-2025
- Dividend Yield
- OLP 7.59%
- EYPT N/A
- EPS Growth
- OLP N/A
- EYPT N/A
- EPS
- OLP 1.35
- EYPT N/A
- Revenue
- OLP $92,152,000.00
- EYPT $56,042,000.00
- Revenue This Year
- OLP $11.87
- EYPT N/A
- Revenue Next Year
- OLP $4.72
- EYPT N/A
- P/E Ratio
- OLP $17.59
- EYPT N/A
- Revenue Growth
- OLP 3.31
- EYPT 12.04
- 52 Week Low
- OLP $22.32
- EYPT $3.91
- 52 Week High
- OLP $30.45
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- OLP 39.64
- EYPT 72.76
- Support Level
- OLP $23.67
- EYPT $7.94
- Resistance Level
- OLP $25.51
- EYPT $10.77
- Average True Range (ATR)
- OLP 0.53
- EYPT 0.74
- MACD
- OLP -0.15
- EYPT 0.10
- Stochastic Oscillator
- OLP 6.28
- EYPT 85.87
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.